Veracyte, Inc.
VCYT
$28.61
-$0.46-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 148.73% | 148.48% | 132.44% | 81.45% | -85.96% |
| Total Depreciation and Amortization | -8.02% | -11.02% | -13.72% | -14.11% | -5.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.17% | -51.04% | -48.94% | 0.89% | 155.02% |
| Change in Net Operating Assets | -7.57% | 16.09% | -412.11% | -162.06% | -335.97% |
| Cash from Operations | 85.68% | 138.92% | 69.82% | 72.14% | 60.96% |
| Capital Expenditure | 7.01% | 1.17% | -13.31% | -3.29% | -23.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -299.42% | -100.00% | -100.00% |
| Cash from Investing | -1,988.71% | -1,722.18% | -472.39% | 47.52% | -286.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 138.87% | 132.90% | 108.74% | 92.44% | -7.80% |
| Repurchase of Common Stock | -98.50% | -95.37% | -57.08% | -37.45% | -94.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -959.17% | -348.61% | 72.86% | 340.22% | -103.28% |
| Foreign Exchange rate Adjustments | 900.00% | -4,940.00% | -360.12% | -54.18% | -140.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.24% | -171.15% | -62.62% | 121.19% | 18.86% |